13G Filing: Healthcor Management LP and Bioverativ Inc (BIVV)

Page 15 of 17

Page 15 of 17 – SEC Filing

CUSIP
No. 097075E100
13G Page
15 of 17 Pages
By virtue of its position
as the investment manager of the Funds, HealthCor Management, L.P. may be deemed a beneficial owner of all the shares of Common
Stock owned by the Funds, as well as those it manages through separately managed accounts.  HealthCor Associates,
LLC is the general partner of HealthCor Management, L.P. and thus may also be deemed to beneficially own the shares of Common
Stock that are beneficially owned by the Funds.
As the Managers of HealthCor Associates,
LLC, Arthur Cohen and Joseph Healey exercise both voting and investment power with respect to the shares of Common Stock reported
herein, and therefore each may be deemed a beneficial owner of such Common Stock.
Each of the Reporting Persons hereby
disclaims any beneficial ownership of any such shares of Common Stock in excess of their actual pecuniary interest therein.
Item 5. Ownership of Five Percent or Less of a Class:
If this statement is being filed to
report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent
of the class of securities, check the following
¨.
Item 6. Ownership of More than Five Percent
on Behalf of Another Person.
Not Applicable
Item 7.   Identification and Classification of
the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
Not Applicable
Item 8. Identification and Classification of
Members of the Group.
See Exhibit I.
Item 9. Notice of Dissolution of Group.
Not Applicable
Item 10. Certification.
By signing below I certify that, to
the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of
or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not
held in connection with or as a participant in any transaction having that purpose or effect.
Exhibits:
Exhibit I: Joint Acquisition Statement

Follow Bioverativ Inc.

Page 15 of 17